Parkworth Wealth Management, Inc. Bristol Myers Squibb CO Transaction History
Parkworth Wealth Management, Inc.
- $139 Billion
- Q2 2025
A detailed history of Parkworth Wealth Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Parkworth Wealth Management, Inc. holds 15 shares of BMY stock, worth $702. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15
Previous 24
37.5%
Holding current value
$702
Previous $1.46 Million
52.6%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,680Shares Held
1.58BCall Options Held
28.2MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...